Thus at the doses of inhibiting implanted tumor growth RGDV-gemcitabine, but not gemcitabine, effectively decrease of serum IL-8 and TNF-ɑ of C57BL/6 mice. This evidence concerns the gene CXCL8 and neoplasm.